What is MicroPort Scientific Corporation?
MicroPort Scientific Corporation, together with its subsidiaries, engages in the innovating, manufacturing, and marketing medical devices globally in the People's Republic of China, Europe, Middle East and Africa, Japan, and internationally.
MCRPF · Verdict
Moderate reward · elevated risk
MCRPF's standout is volatility; balance sheet and cash flow weigh on the picture.
Based on 88% data coverage
MCRPF · Verdict
Top decile vs peers
Net debt/EBITDA 16.2×
-15% free-cash-flow margin
-21% net margin · -16% ROE
P/E 526.3×
Rev +10.0% CAGR · earnings -8.1%
Model-based scoring. For information only — not financial advice.
MicroPort Scientific Corporation, together with its subsidiaries, engages in the innovating, manufacturing, and marketing medical devices globally in the People's Republic of China, Europe, Middle East and Africa, Japan, and internationally. The company's Cardiovascular Devices segment offers medical solutions for the treatment of coronary artery-related diseases; and coronary stents, related delivery systems, balloon catheters, accessories, and active devices. The company is listed on the PINK in USA, operating in the Healthcare sector, with a market capitalisation of 3.27B.
The scoring profile indicates limited reward potential at this time, with momentum and size offering the most support. Risk indicators are elevated — volatility and macro sensitivity warrant consideration.
For informational purposes only. Not financial advice.